Wordt geladen...
Lurasidone as a potential therapy for bipolar disorder
Lurasidone is a benzisothiazol derivative and an atypical antipsychotic approved by the US Food and Drug Administration for the acute treatment of adults with schizophrenia (October 2010) and bipolar 1 depression (June 2013). Lurasidone has a strong antagonistic property at the D(2), serotonin (5-HT...
Bewaard in:
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Dove Medical Press
2013
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3797281/ https://ncbi.nlm.nih.gov/pubmed/24143101 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S51910 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|